A detailed history of Alera Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Alera Investment Advisors, LLC holds 10,310 shares of NVO stock, worth $1.05 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
10,310
Previous 11,080 6.95%
Holding current value
$1.05 Million
Previous $1.58 Million 22.39%
% of portfolio
0.15%
Previous 0.19%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $91,683 - $111,973
-770 Reduced 6.95%
10,310 $1.23 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $704,232 - $843,116
-5,739 Reduced 34.12%
11,080 $1.58 Million
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $26,854 - $35,746
-263 Reduced 1.54%
16,819 $2.16 Million
Q4 2023

Jan 23, 2024

SELL
$87.78 - $105.45 $34,234 - $41,125
-390 Reduced 2.23%
17,082 $1.77 Million
Q3 2023

Oct 11, 2023

BUY
$90.94 - $199.54 $790,996 - $1.74 Million
8,698 Added 99.13%
17,472 $1.59 Million
Q2 2023

Jul 26, 2023

BUY
$155.98 - $172.65 $102,790 - $113,776
659 Added 8.12%
8,774 $1.42 Million
Q1 2023

May 01, 2023

BUY
$132.34 - $159.14 $20,909 - $25,144
158 Added 1.99%
8,115 $1.29 Million
Q4 2022

Feb 02, 2023

SELL
$102.55 - $135.33 $18,253 - $24,088
-178 Reduced 2.19%
7,957 $1.08 Million
Q3 2022

Nov 09, 2022

SELL
$95.28 - $116.93 $952 - $1,169
-10 Reduced 0.12%
8,135 $810,000
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $631,519 - $745,111
6,117 Added 301.63%
8,145 $908,000
Q1 2022

May 10, 2022

BUY
$93.1 - $112.54 $188,806 - $228,231
2,028 New
2,028 $225,000
Q2 2019

Aug 07, 2019

SELL
$46.79 - $52.47 $49,878 - $55,933
-1,066 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$46.36 - $52.63 $6,536 - $7,420
141 Added 15.24%
1,066 $56,000
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $38,424 - $43,706
925 New
925 $43,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Alera Investment Advisors, LLC Portfolio

Follow Alera Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alera Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alera Investment Advisors, LLC with notifications on news.